Literature DB >> 3244016

Presence of dolichol and its derivatives in human blood.

P G Elmberger1, P Engfeldt, G Dallner.   

Abstract

Optimal conditions for the quantitative estimation of dolichol in human plasma were determined. Because of the large amounts of other lipids present in the blood, the extraction procedure, the procedure for hydrolysis, and the HPLC procedure are of decisive importance. Human plasma contains dolichol, dolichyl esters, and dolichyl phosphate at concentrations of 41, 102, and 55 ng/g, respectively. These polyisoprenoid lipids are associated with the high density lipoprotein fraction. The relative amounts and compositions of dolichyl esters in the plasma are similar to those observed in isolated human liver microsomes and Golgi vesicles. Sixty percent of the fatty acids present are saturated and almost no long-chain polyunsaturated components are present. There is no correlation between blood dolichol content and weight, sex, dietary state, or plasma cholesterol level, but there is an inverse relationship to plasma triglyceride content. A linear increase in the total plasma dolichol content with increasing age was found. In a few pathological conditions where the level of blood cholesterol was increased, the total blood dolichol content was not affected. Apparently, dolichol is a stable lipid component of human high density lipoprotein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244016

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  Lipidomics reveals a remarkable diversity of lipids in human plasma.

Authors:  Oswald Quehenberger; Aaron M Armando; Alex H Brown; Stephen B Milne; David S Myers; Alfred H Merrill; Sibali Bandyopadhyay; Kristin N Jones; Samuel Kelly; Rebecca L Shaner; Cameron M Sullards; Elaine Wang; Robert C Murphy; Robert M Barkley; Thomas J Leiker; Christian R H Raetz; Ziqiang Guan; Gregory M Laird; David A Six; David W Russell; Jeffrey G McDonald; Shankar Subramaniam; Eoin Fahy; Edward A Dennis
Journal:  J Lipid Res       Date:  2010-07-29       Impact factor: 5.922

2.  Discharge of newly-synthesized dolichol and ubiquinone with lipoproteins to rat liver perfusate and to the bile.

Authors:  P G Elmberger; A Kalén; U T Brunk; G Dallner
Journal:  Lipids       Date:  1989-11       Impact factor: 1.880

3.  Aberrant dolichol chain lengths as biomarkers for retinitis pigmentosa caused by impaired dolichol biosynthesis.

Authors:  Rong Wen; Byron L Lam; Ziqiang Guan
Journal:  J Lipid Res       Date:  2013-09-27       Impact factor: 5.922

4.  Biliary excretion of dolichols and beta-hexosaminidase--effect of ethanol and glucagon.

Authors:  K Humaloja; M Salaspuro; R P Roine
Journal:  Lipids       Date:  1997-11       Impact factor: 1.880

5.  Low-density lipoprotein as a transporter of dolichol intermediates in the mammalian circulation.

Authors:  J W Rip; M M Blais; L W Jiang
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

6.  Age-related changes in the lipid compositions of rat and human tissues.

Authors:  A Kalén; E L Appelkvist; G Dallner
Journal:  Lipids       Date:  1989-07       Impact factor: 1.880

7.  Uptake and metabolism of dolichol and cholesterol in perfused rat liver.

Authors:  A Kalén; M Söderberg; P G Elmberger; G Dallner
Journal:  Lipids       Date:  1990-02       Impact factor: 1.880

8.  Transfer of liposomes containing dolichol into isolated hepatocytes.

Authors:  O Tollbom; T Chojnacki; G Dallner
Journal:  Lipids       Date:  1992-04       Impact factor: 1.880

9.  Nonmembrane associated dolichol in rat liver.

Authors:  P Löw; E Peterson; C Edlund; U Brunk; E L Appelkvist
Journal:  Lipids       Date:  1992-01       Impact factor: 1.880

10.  Quantification of dolichol in the human lens with different types of cataracts.

Authors:  Devarshi Gajjar; Adam Jozwiak; Ewa Swiezewska; Bhagwat Alapure; Trilok Parmar; Kaid Johar; Abhay R Vasavada
Journal:  Mol Vis       Date:  2009-08-11       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.